| __timestamp | Exelixis, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 50829000 | 406114000 |
| Thursday, January 1, 2015 | 57305000 | 449119000 |
| Friday, January 1, 2016 | 116145000 | 502892000 |
| Sunday, January 1, 2017 | 159362000 | 544156000 |
| Monday, January 1, 2018 | 206366000 | 683530000 |
| Tuesday, January 1, 2019 | 228244000 | 736942000 |
| Wednesday, January 1, 2020 | 293355000 | 854233000 |
| Friday, January 1, 2021 | 401715000 | 1451683000 |
| Saturday, January 1, 2022 | 459856000 | 1416967000 |
| Sunday, January 1, 2023 | 542705000 | 1343105000 |
| Monday, January 1, 2024 | 492128000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Exelixis, Inc. and Jazz Pharmaceuticals plc have shown contrasting strategies in optimizing these costs. From 2014 to 2023, Jazz Pharmaceuticals consistently reported higher SG&A expenses, peaking at approximately 1.45 billion in 2021. This represents a staggering 257% increase from their 2014 figures. In contrast, Exelixis, Inc. demonstrated a more conservative growth in SG&A expenses, with a 967% increase over the same period, reaching around 543 million in 2023.
While Jazz Pharmaceuticals' higher expenses might indicate aggressive market expansion, Exelixis' more modest increase suggests a focus on cost efficiency. This comparison highlights the diverse strategies companies employ to balance growth and cost management in the pharmaceutical industry.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Exelixis, Inc. and Merus N.V.
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and HUTCHMED (China) Limited
Comparing SG&A Expenses: Exelixis, Inc. vs Novavax, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.